Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Signaling kinase AMPK activates stress-promoted transcription via histone H2B phosphorylation.

Bungard D, Fuerth BJ, Zeng PY, Faubert B, Maas NL, Viollet B, Carling D, Thompson CB, Jones RG, Berger SL.

Science. 2010 Sep 3;329(5996):1201-5. doi: 10.1126/science.1191241. Epub 2010 Jul 15.

2.

AMPK regulates the circadian clock by cryptochrome phosphorylation and degradation.

Lamia KA, Sachdeva UM, DiTacchio L, Williams EC, Alvarez JG, Egan DF, Vasquez DS, Juguilon H, Panda S, Shaw RJ, Thompson CB, Evans RM.

Science. 2009 Oct 16;326(5951):437-40. doi: 10.1126/science.1172156.

3.

Cre activity in fetal albCre mouse hepatocytes: Utility for developmental studies.

Weisend CM, Kundert JA, Suvorova ES, Prigge JR, Schmidt EE.

Genesis. 2009 Dec;47(12):789-92. doi: 10.1002/dvg.20568.

4.

Circadian rhythms of extracellular ATP accumulation in suprachiasmatic nucleus cells and cultured astrocytes.

Womac AD, Burkeen JF, Neuendorff N, Earnest DJ, Zoran MJ.

Eur J Neurosci. 2009 Sep;30(5):869-76. doi: 10.1111/j.1460-9568.2009.06874.x. Epub 2009 Aug 27.

5.

Deficiency of the intestinal enzyme acyl CoA:monoacylglycerol acyltransferase-2 protects mice from metabolic disorders induced by high-fat feeding.

Yen CL, Cheong ML, Grueter C, Zhou P, Moriwaki J, Wong JS, Hubbard B, Marmor S, Farese RV Jr.

Nat Med. 2009 Apr;15(4):442-6. doi: 10.1038/nm.1937. Epub 2009 Mar 15.

6.

Absence of the SRC-2 coactivator results in a glycogenopathy resembling Von Gierke's disease.

Chopra AR, Louet JF, Saha P, An J, Demayo F, Xu J, York B, Karpen S, Finegold M, Moore D, Chan L, Newgard CB, O'Malley BW.

Science. 2008 Nov 28;322(5906):1395-9. doi: 10.1126/science.1164847.

7.

Steroid receptor coactivator 2 is critical for progesterone-dependent uterine function and mammary morphogenesis in the mouse.

Mukherjee A, Soyal SM, Fernandez-Valdivia R, Gehin M, Chambon P, Demayo FJ, Lydon JP, O'Malley BW.

Mol Cell Biol. 2006 Sep;26(17):6571-83.

8.

Activation of AMP-activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders.

Viollet B, Foretz M, Guigas B, Horman S, Dentin R, Bertrand L, Hue L, Andreelli F.

J Physiol. 2006 Jul 1;574(Pt 1):41-53. Epub 2006 Apr 27. Review.

9.

Exocrine pancreatic function in children with progressive familial intrahepatic cholestasis type 2.

Walkowiak J, Jankowska I, Pawlowska J, Strautnieks S, Bull L, Thompson R, Herzig KH, Socha J.

J Pediatr Gastroenterol Nutr. 2006 Apr;42(4):416-8.

PMID:
16641580
10.

Prevalence of overweight and obesity in the United States, 1999-2004.

Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM.

JAMA. 2006 Apr 5;295(13):1549-55.

PMID:
16595758
11.

5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside and metformin inhibit hepatic glucose phosphorylation by an AMP-activated protein kinase-independent effect on glucokinase translocation.

Guigas B, Bertrand L, Taleux N, Foretz M, Wiernsperger N, Vertommen D, Andreelli F, Viollet B, Hue L.

Diabetes. 2006 Apr;55(4):865-74.

12.

The genomic analysis of the impact of steroid receptor coactivators ablation on hepatic metabolism.

Jeong JW, Kwak I, Lee KY, White LD, Wang XP, Brunicardi FC, O'Malley BW, DeMayo FJ.

Mol Endocrinol. 2006 May;20(5):1138-52. Epub 2006 Jan 19.

PMID:
16423883
13.

Intestinal cholesterol absorption is substantially reduced in mice deficient in both ABCA1 and ACAT2.

Temel RE, Lee RG, Kelley KL, Davis MA, Shah R, Sawyer JK, Wilson MD, Rudel LL.

J Lipid Res. 2005 Nov;46(11):2423-31. Epub 2005 Sep 8.

14.

AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism.

Kahn BB, Alquier T, Carling D, Hardie DG.

Cell Metab. 2005 Jan;1(1):15-25. Review.

15.

Reversal of obesity by targeted ablation of adipose tissue.

Kolonin MG, Saha PK, Chan L, Pasqualini R, Arap W.

Nat Med. 2004 Jun;10(6):625-32. Epub 2004 May 9.

PMID:
15133506
16.

Cholesterol feeding of mice expressing cholesterol 7alpha-hydroxylase increases bile acid pool size despite decreased enzyme activity.

Tiemann M, Han Z, Soccio R, Bollineni J, Shefer S, Sehayek E, Breslow JL.

Proc Natl Acad Sci U S A. 2004 Feb 17;101(7):1846-51. Epub 2004 Feb 4.

17.

The AMP-activated protein kinase cascade--a unifying system for energy control.

Carling D.

Trends Biochem Sci. 2004 Jan;29(1):18-24. Review.

PMID:
14729328
18.

The farnesoid X receptor controls gene expression in a ligand- and promoter-selective fashion.

Lew JL, Zhao A, Yu J, Huang L, De Pedro N, Peláez F, Wright SD, Cui J.

J Biol Chem. 2004 Mar 5;279(10):8856-61. Epub 2003 Dec 18.

19.

SRC-1 and TIF2 control energy balance between white and brown adipose tissues.

Picard F, Géhin M, Annicotte J, Rocchi S, Champy MF, O'Malley BW, Chambon P, Auwerx J.

Cell. 2002 Dec 27;111(7):931-41.

20.

Natural structural variants of the nuclear receptor farnesoid X receptor affect transcriptional activation.

Zhang Y, Kast-Woelbern HR, Edwards PA.

J Biol Chem. 2003 Jan 3;278(1):104-10. Epub 2002 Oct 19.

Supplemental Content

Support Center